LAEVADOSIN IN TREATMENT OF DUCHENNE TYPE OF MUSCULAR DYSTROPHY: PRELIMINARY RESULTS OF A DOUBLE-BLIND CONTROLLED TRIAL.
D000293:Adolescent; D035843:Biomedical Research; D002648:Child; D004796:Clinical Enzyme Tests; D003402:Creatine Kinase; D004311:Double-Blind Method; D004358:Drug Therapy; D006801:Humans; D007267:Injections; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D009136:Muscular Dystrophies; D009705:Nucleosides; D009711:Nucleotides; D011379:Prognosis; D013223:Statistics as Topic
D009705:Nucleosides; D009711:Nucleotides; D003402:Creatine Kinase
ADOLESCENCE; CHILD; CLINICAL RESEARCH; CREATINE KINASE; DRUG THERAPY; ENZYME TESTS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MUSCULAR DYSTROPHY; NUCLEOSIDES; NUCLEOTIDES; PROGNOSIS; STATISTICS